Saikat Das on Muck Rack

Saikat Das

Verified
Mumbai
As seen in: Bloomberg News, Medium, MSN, 7@7, Arthritis & Rheumatology, Bangalore Mirror, Bloomberg Green Daily, Color Research & Application, ET BFSI, ET Energy World, ETCFO and
Currently employed with @Bloomberg. Served @economictimes for nearly a decade. Write on credit, corporate finance, banking and markets. No endorsement!
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Saikat

Contact Saikat, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

SBI in $1 billion funding for Sun Pharma’s US deal

|
By Saikat Das 
| The Economic Times
Mumbai: State Bank of India plans to join a group of global lenders in funding Sun Pharmaceutical Industries Ltd.’s $12 billion overseas acquisition, according to people familiar with the matter. SBI, the country’s largest bank by assets, is set to commit as much as $1 billion, the people said, asking not to be identified discussing a private matter. The proposal is pending board approval, the people said.
Open in Who Shared Issue with article?

SBI in $1 billion funding for Sun Pharma’s US deal

|
By Saikat Das 
| ETLegalworld
State Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co. This move marks a significant step for government-run banks in financing corporate takeovers. SBI will join other global lenders in this substantial deal. The funding underscores the growing ambition of Indian companies to expand globally.
Open in Who Shared Issue with article?

SBI in $1 billion funding for Sun Pharma’s US deal

|
By Saikat Das 
| ETCFO
State Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co. This move marks a significant step for government-run banks in financing corporate takeovers. SBI will join other global lenders in this substantial deal. The funding underscores the growing ambition of Indian companies to expand globally.
Open in Who Shared Issue with article?
See all 4,428 licensed articles (6,456 Total)

Actions

Share this page

Get in touch with Saikat

Contact Saikat, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified